| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2014 | WO2014011624A2 Stabilized multi-functional antioxidant compounds and methods of use |
| 01/16/2014 | WO2014011590A2 Composition and method for treatment of depression and psychosis in humans |
| 01/16/2014 | WO2014011568A1 Azaindole derivatives which act as pi3k inhibitors |
| 01/16/2014 | WO2014011513A1 Sulfonyl containing benzothiazole inhibitors of endothelial lipase |
| 01/16/2014 | WO2014011461A1 Amide or urea substituted benzothiazole derivatives as inhibitors of endothelial lipase |
| 01/16/2014 | WO2014011284A1 Method of treating gastrointestinal stromal tumors |
| 01/16/2014 | WO2014011273A2 Pro-inflammatory mediators in diagnosis and treatment of pulmonary disease |
| 01/16/2014 | WO2014011235A1 Methods of inducing anesthesia |
| 01/16/2014 | WO2014011220A2 A method of treating androgen receptor (ar)-positive breast cancers with selective androgen receptor modulator (sarms) |
| 01/16/2014 | WO2014011120A1 Endoperoxides, synthesis and uses thereof for the treatment of neoplastic diseases such as cancer |
| 01/16/2014 | WO2014011053A1 Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell |
| 01/16/2014 | WO2014011050A1 Exon replacement with stabilized artificial rnas |
| 01/16/2014 | WO2014011047A1 Chromanyl derivatives for treating mitochondrial disease |
| 01/16/2014 | WO2014010948A1 Pharmaceutical composition comprising azathioprine as active ingredient for preventing or treating brain tumors or temodal-resistant glioblastomas |
| 01/16/2014 | WO2014010924A1 Pharmaceutical composition for topical administration comprising vancomycin or its salt and dexamethasone phosphate or its salt |
| 01/16/2014 | WO2014010900A1 Composition for preventing or treating hair loss or promoting hair growth comprising secoiridoid glucoside derivatives |
| 01/16/2014 | WO2014010896A1 Pharmaceutical composition for preventing, alleviating, or treating heart failure, and complex formulations comprising same |
| 01/16/2014 | WO2014010748A1 Cyclopropane derivative having bace1 inhibiting activity |
| 01/16/2014 | WO2014010742A1 Pharmaceutical composition or food product composition comprising monogalactosyldiacylglycerol or pharmaceutically acceptable salt thereof as active ingredient |
| 01/16/2014 | WO2014010737A1 Oxime-substituted amide compound and pest control agent |
| 01/16/2014 | WO2014010732A1 Heterocyclic compound |
| 01/16/2014 | WO2014010656A1 Superior blood alcohol concentration reduction accelerating agent |
| 01/16/2014 | WO2014010654A2 Sulfonamide compound combination |
| 01/16/2014 | WO2014010603A1 Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed incontinence, and method for screening compounds to be included in said pharmaceutical composition |
| 01/16/2014 | WO2014010602A1 Indolecarboxamide derivative |
| 01/16/2014 | WO2014010528A1 Oxaliplatin-containing pharmaceutical composition |
| 01/16/2014 | WO2014010244A1 Food composition with improved flavor persistence |
| 01/16/2014 | WO2014010206A1 Immune tolerance inducer |
| 01/16/2014 | WO2014010008A1 Capsule-filling composition of candesartan cilexetil |
| 01/16/2014 | WO2014009970A2 Linagliptin solid dispersion |
| 01/16/2014 | WO2014009957A1 A process for obtaining polyhydroxylated fatty alcohols from avocado seed and their use in cosmetcs and medicine |
| 01/16/2014 | WO2014009936A1 Compositions for the treatment of neuropathic pain |
| 01/16/2014 | WO2014009926A1 Pediatric oral liquid compositions containing nepadutant |
| 01/16/2014 | WO2014009923A1 Compositions containing monoglycerides of c8 to c14 organic acids and glycerol, and animal feeds comprising th |
| 01/16/2014 | WO2014009891A1 Heterocyclic compounds for use in the treatment of cancers |
| 01/16/2014 | WO2014009872A1 Tetrahydroquinazolinone derivatives as parp inhibitors |
| 01/16/2014 | WO2014009860A1 Novel therapy in the treatment of alkaptonuria |
| 01/16/2014 | WO2014009817A1 Pharmaceutical composition of febuxostat |
| 01/16/2014 | WO2014009794A1 Compounds and methods for treating hiv |
| 01/16/2014 | WO2014009793A1 Diclofenac solution for external use |
| 01/16/2014 | WO2014009779A1 Selective inhibition of the membrane attack complex of complement and c3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex |
| 01/16/2014 | WO2014009739A1 Method for treating microorganism infections |
| 01/16/2014 | WO2014009738A2 Treatment of muscular dystrophy |
| 01/16/2014 | WO2014009609A1 Combination therapy iii |
| 01/16/2014 | WO2014009509A1 Macrocyclic purines for the treatment of viral infections |
| 01/16/2014 | WO2014009500A1 Anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea |
| 01/16/2014 | WO2014009495A1 Antiproliferative benzo [b] azepin- 2 - ones |
| 01/16/2014 | WO2014009437A1 Oxidation stability of abiraterone acetate |
| 01/16/2014 | WO2014009436A1 Nanosuspension of abiraterone acetate |
| 01/16/2014 | WO2014009434A1 Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate |
| 01/16/2014 | WO2014009425A1 Inhibition of enzymes |
| 01/16/2014 | WO2014009319A1 Indolinone derivatives anticancer compounds |
| 01/16/2014 | WO2014009318A1 3-{3-[1 -(4-dimethylaminomethyl-phenylamino)-1 -phenyl-meth-(z)-ylidene]-2-oxo-2,3-dihydro-1 h-indol-6-yll-propynoic acid ethylamide and its use in the treatment of cancer |
| 01/16/2014 | WO2014009305A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/16/2014 | WO2014009302A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 01/16/2014 | WO2014009296A1 Imidazopyrazine derivatives as modulators of tnf activity |
| 01/16/2014 | WO2014009295A1 Imidazopyridine derivatives as modulators of tnf activity |
| 01/16/2014 | WO2014009274A1 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments |
| 01/16/2014 | WO2014009241A1 Diclofenac formulations |
| 01/16/2014 | WO2014009222A1 Combination therapy for the treatment of cancer and immunosuppression |
| 01/16/2014 | WO2014009219A1 Method for preparing substituted triazolopyridines |
| 01/16/2014 | WO2014008992A1 Pyrimidine pyrazolyl derivatives |
| 01/16/2014 | WO2014008838A1 Bis-indolylacetic acid derivative attached with aryl substituted methyl, and preparation method and use thereof |
| 01/16/2014 | WO2014008794A1 Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof |
| 01/16/2014 | WO2014008673A1 Allopurinol derivative and preparation method and application thereof |
| 01/16/2014 | WO2014008648A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof |
| 01/16/2014 | WO2014008636A1 Macrocyclic compounds as hiv integrase inhibitors |
| 01/16/2014 | WO2014008629A1 Novel derivatives of donepezil |
| 01/16/2014 | WO2014008610A1 Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection |
| 01/16/2014 | WO2014008609A1 Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases |
| 01/16/2014 | WO2014008608A1 Acellular pro-tolerogenic compositions and process for making same |
| 01/16/2014 | WO2014008602A1 Solid maple syrup compositions |
| 01/16/2014 | WO2014008592A1 Combinations comprising diamidine compounds and parp inhibitors for use iν treating cancer |
| 01/16/2014 | WO2014008542A1 Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders |
| 01/16/2014 | WO2013179289A8 Pyrazolotriazolyl nucleoside analogues and oligonucleotides comprising them |
| 01/16/2014 | WO2013177594A3 Xylitol-based anti-mucosal compositions and related methods and compositions |
| 01/16/2014 | WO2013177559A3 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
| 01/16/2014 | WO2013177478A3 Treatment method |
| 01/16/2014 | WO2013177420A3 Methods and compositions for the treatment of bcr-abl positive lymphoblastic leukemias |
| 01/16/2014 | WO2013175474A3 Selective inhibitors of undifferentiated cells |
| 01/16/2014 | WO2013165898A3 Compositions and methods for inhibiting resolvases |
| 01/16/2014 | WO2013165816A3 SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
| 01/16/2014 | WO2013163159A3 Design and synthesis of novel inhibitors of isoprenoid biosynthesis |
| 01/16/2014 | WO2012174487A8 Bromodomain inhibitors and uses thereof |
| 01/16/2014 | US20140018909 Treatment to Render Implants Resistant to Diabetes |
| 01/16/2014 | US20140018552 Use of compounds isolated from morus bark |
| 01/16/2014 | US20140018545 Inhibitors of Dipeptidylpeptidase IV |
| 01/16/2014 | US20140018438 Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin |
| 01/16/2014 | US20140018437 Treatment of inflammatory and infectious skin disorders |
| 01/16/2014 | US20140018435 Transdermal Delivery of Therapeutic Agents Using Poly (Amidoamine) Dendrimers |
| 01/16/2014 | US20140018434 Cleaning, insecticide, insect repellant, glue solvent and anti-irritation composition |
| 01/16/2014 | US20140018433 Method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms) |
| 01/16/2014 | US20140018431 Treprostinil treatment for interstitial lung disease and asthma |
| 01/16/2014 | US20140018430 Novel composition for the treatment of cystic fibrosis |
| 01/16/2014 | US20140018429 Protection of normal cells |
| 01/16/2014 | US20140018427 Diclofenac topical formulation |
| 01/16/2014 | US20140018426 Food or beverage composition fortified with thyronamines and/or thyronamine precursors |
| 01/16/2014 | US20140018424 Preventive effect of citrulline on the spontaneous development of tumors |
| 01/16/2014 | US20140018420 Ferric organic compounds, uses thereof and methods of making same |
| 01/16/2014 | US20140018418 Methods of treating or preventing h5n1 influenza |